Journals / Turkish Journal of Medical Sciences / 1998 / Cilt: 28 - Sayı: 4

The Effect of Treatment Types on Plasma Levels of Lipoproteins, Apolipoproteins and LCAT in Type II Diabetes Mellitus

Pages
423–429
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

TC (total cholesterol), LDL, TC/HDL, LDL/HDL levels found high before treatment in the OAD (oral antidiabetic) group (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this studry 32 hyperglycemic patients with type II DM were treated with diet (7 patients), with gliclazide, an oral antidiabetic agent (10 patients), or with insulin (15 patients).
📊
Key Findings & Data:The levels of liporoteins, apolipoprotein A and B and LCAT enzyme are measured before the therapy and 3 weeks after the achievement of glycemic control.
💡
Conclusion & Impact:TC (total cholesterol), LDL, TC/HDL, LDL/HDL levels found high before treatment in the OAD (oral antidiabetic) group (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Diabetes Mellitus · Plasma Lipoproteins · Apolipoproteins

Abstract

In this studry 32 hyperglycemic patients with type II DM were treated with diet (7 patients), with gliclazide, an oral antidiabetic agent (10 patients), or with insulin (15 patients). The levels of liporoteins, apolipoprotein A and B and LCAT enzyme are measured before the therapy and 3 weeks after the achievement of glycemic control. Treatment types are compared with each other and with control group (10 normal persons) triglyseride (TG) and VLDL levels which were found to be high in all of the patients decreased in all groups to levels similar to control group. TC (total cholesterol), LDL, TC/HDL, LDL/HDL levels found high before treatment in the OAD (oral antidiabetic) group (p

Özet

In this studry 32 hyperglycemic patients with type II DM were treated with diet (7 patients), with gliclazide, an oral antidiabetic agent (10 patients), or with insulin (15 patients). The levels of liporoteins, apolipoprotein A and B and LCAT enzyme are measured before the therapy and 3 weeks after the achievement of glycemic control. Treatment types are compared with each other and with control group (10 normal persons) triglyseride (TG) and VLDL levels which were found to be high in all of the patients decreased in all groups to levels similar to control group. TC (total cholesterol), LDL, TC/HDL, LDL/HDL levels found high before treatment in the OAD (oral antidiabetic) group (p

🔖

Cite This Article

VARDARELİ, E., AKYÜZ, F., İNAL, M., ERENOĞLU, E., EFE, B. (2022). The Effect of Treatment Types on Plasma Levels of Lipoproteins, Apolipoproteins and LCAT in Type II Diabetes Mellitus. Turkish Journal of Medical Sciences, Cilt: 28 - Sayı: 4, 423–429. https://ajindex.com/articles/612688

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...